KARBE FRANK (Chief Financial Officer) reported 2 transactions at CIDARA THERAPEUTICS, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 1/7/2026ACC: 0001276700-26-000002
Officer· Chief Financial Officer
Since Feb 2025
-165.65K
Net shares
Net seller
$1.67M
Total sold
0
Open market trades
0B · 0S
3
Total transactions
165.65K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−7.53K
Price / share
$221.50
Trade value
$1.67M
% of position
14.9%
1/7/2026
50.65K→43.13K
Common Stock
Direct
Shares
−43.13K
Price / share
—
Trade value
—
% of position
New position
1/7/2026
43.13K→0.00
Total
Net shares
−50.65K
Net value
-$1.67M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/7/2026 | D · Disposition | −7.53K | $221.50 | $1.67M | 14.9% | 50.65K | 43.13K |
| Common Stock Direct | 1/7/2026 | D · Disposition | −43.13K | — | — | New position | 43.13K | 0.00 |
| Total | −50.65K | -$1.67M | ||||||
Derivative Transactions1
Employee Stock Option (right to buy)
Direct
Converts to
Common Stock
115K shares
Shares
−115K
Strike price
20.50
Held after
0.00
Exercisable
—
1/7/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy) Direct | Common Stock115K shares | 1/7/2026 | D · Disposition | −115K | 20.50 | — | 0.00 |